Newron Pharmaceuticals Statistics
Total Valuation
SWX:NWRN has a market cap or net worth of CHF 215.98 million. The enterprise value is 224.73 million.
Market Cap | 215.98M |
Enterprise Value | 224.73M |
Important Dates
The last earnings date was Tuesday, September 16, 2025.
Earnings Date | Sep 16, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SWX:NWRN has 19.96 million shares outstanding. The number of shares has increased by 16.86% in one year.
Current Share Class | 19.96M |
Shares Outstanding | 19.96M |
Shares Change (YoY) | +16.86% |
Shares Change (QoQ) | -11.63% |
Owned by Insiders (%) | 5.40% |
Owned by Institutions (%) | 6.22% |
Float | 18.88M |
Valuation Ratios
The trailing PE ratio is 9.73.
PE Ratio | 9.73 |
Forward PE | n/a |
PS Ratio | 3.86 |
PB Ratio | 146.17 |
P/TBV Ratio | 146.27 |
P/FCF Ratio | 9.43 |
P/OCF Ratio | 9.41 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.80, with an EV/FCF ratio of 9.81.
EV / Earnings | 9.50 |
EV / Sales | 4.02 |
EV / EBITDA | 6.80 |
EV / EBIT | 6.84 |
EV / FCF | 9.81 |
Financial Position
The company has a current ratio of 1.51, with a Debt / Equity ratio of 33.23.
Current Ratio | 1.51 |
Quick Ratio | 1.40 |
Debt / Equity | 33.23 |
Debt / EBITDA | 1.49 |
Debt / FCF | 2.14 |
Interest Coverage | 8.00 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | 50.97% |
Return on Invested Capital (ROIC) | 60.97% |
Return on Capital Employed (ROCE) | 165.16% |
Revenue Per Employee | 2.54M |
Profits Per Employee | 1.08M |
Employee Count | 22 |
Asset Turnover | 1.39 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, SWX:NWRN has paid 5.19 million in taxes.
Income Tax | 5.19M |
Effective Tax Rate | 17.99% |
Stock Price Statistics
The stock price has increased by +38.58% in the last 52 weeks. The beta is 0.75, so SWX:NWRN's price volatility has been lower than the market average.
Beta (5Y) | 0.75 |
52-Week Price Change | +38.58% |
50-Day Moving Average | 8.45 |
200-Day Moving Average | 8.20 |
Relative Strength Index (RSI) | 66.91 |
Average Volume (20 Days) | 100,804 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SWX:NWRN had revenue of CHF 55.93 million and earned 23.65 million in profits. Earnings per share was 1.11.
Revenue | 55.93M |
Gross Profit | 55.93M |
Operating Income | 32.88M |
Pretax Income | 28.84M |
Net Income | 23.65M |
EBITDA | 32.89M |
EBIT | 32.88M |
Earnings Per Share (EPS) | 1.11 |
Balance Sheet
The company has 40.34 million in cash and 49.10 million in debt, giving a net cash position of -8.75 million or -0.44 per share.
Cash & Cash Equivalents | 40.34M |
Total Debt | 49.10M |
Net Cash | -8.75M |
Net Cash Per Share | -0.44 |
Equity (Book Value) | 1.48M |
Book Value Per Share | 0.07 |
Working Capital | 19.04M |
Cash Flow
In the last 12 months, operating cash flow was 22.94 million and capital expenditures -34,557, giving a free cash flow of 22.91 million.
Operating Cash Flow | 22.94M |
Capital Expenditures | -34,557 |
Free Cash Flow | 22.91M |
FCF Per Share | 1.15 |
Margins
Gross margin is 100.00%, with operating and profit margins of 58.78% and 42.30%.
Gross Margin | 100.00% |
Operating Margin | 58.78% |
Pretax Margin | 51.57% |
Profit Margin | 42.30% |
EBITDA Margin | 58.81% |
EBIT Margin | 58.78% |
FCF Margin | 40.96% |
Dividends & Yields
SWX:NWRN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -16.86% |
Shareholder Yield | n/a |
Earnings Yield | 10.95% |
FCF Yield | 10.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
SWX:NWRN has an Altman Z-Score of 4.83 and a Piotroski F-Score of 5.
Altman Z-Score | 4.83 |
Piotroski F-Score | 5 |